Emergent BioSolutions Announces 2022 Financial Guidance, Provides Preliminary 2021 Results
Go back to Emergent BioSolutions Announces 2022 Financial Guidance, Provides Preliminary 2021 Results| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 6.46 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.46 | 52 Week High | $44.38 | |||
| Open | $6.46 | 52 Week Low | $24.47 | |||
| Day High | $6.46 | P/E | 323.00 | |||
| Day Low | $6.46 | EPS | $0.02 | |||
| Volume | 1,555 | |||||
